Lefibenz-250 ( Gefitinib Tablets)
Description :Gefitinib is a targeted therapy. It is classified as a signal transduction inhibitor (epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor).
Usage : Gefitinib tablets are used for the treatment of locally advanced or metastatic non-small cell lung cancer, after failure of both platinum-based and taxane-based chemotherapies.
Route of Administration: Gefitinib is a pill, taken by mouth, once daily. It can be taken with or without food.
Specification : Gefitinib tablets are film coated tablets contains Gefitinib as acitve material. Packed in 3 blister of 10 tablets in a monocarton along with a leaflet.